Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity.
FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
Future MS care: a consensus statement of the MS in the 21st Century Steering Group.
B-cell-directed therapy: which B cells should be targeted and how?
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease
Lower urinary tract symptoms of neurological origin in urological practice.
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
The effects of aquatic therapy on mobility of individuals with neurological diseases: A systematic review.
Evidence for a two-stage disability progression in multiple sclerosis.
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
[Sociological research in Samara Oblast: a role of social organizations of patients in the improvement of quality of medical and social care].
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.
The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.
Immunomodulatory Effects of Histone Deacetylase Inhibitors.
Hope for a rare disease: eculizumab in neuromyelitis optica.
Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).

Pages